INSIDER · CIK 1758363
Turtle Cameron
Chief Executive Officer, Director at Spyre Therapeutics, Inc. (SYRE)
↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$4.1MSold on the market
1Companies
Oct 2, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202621:29 | Oct 1, 2026 | SYRESpyre Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $92.01 | −15,000 | 537,540 | -3% | −$1.4M | ||
| Sep 3, 202621:33 | Sep 1, 2026 | SYRESpyre Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $87.29 | −15,000 | 552,540 | -3% | −$1.3M | ||
| Aug 5, 202621:31 | Aug 3, 2026 | SYRESpyre Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $95.51 | −15,000 | 567,540 | -3% | −$1.4M |